Endothelial Nogo-B suppresses cancer cell proliferation via a paracrine TGF-&#x03B2;/Smad signaling

Hengyu Li; Zhuo Cheng; Wei Huang; Chenguang Bai; Jian Lin; Yuan Sheng; Weifeng Shen; Xiaojun Wu

doi:10.18632/oncotarget.23672

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Withdrawal Notice

This paper was originally published in Oncotarget Advance Online Publications on 12/26/2017.
In compliance with Oncotarget's withdrawal policy, the paper was withdrawn in its entirety. It will not appear in Oncotarget internal or any external indexes or archives.

Research Papers:

Endothelial Nogo-B suppresses cancer cell proliferation via a paracrine TGF-β/Smad signaling

Hengyu Li, Zhuo Cheng, Wei Huang, Chenguang Bai, Jian Lin, Yuan Sheng, Weifeng Shen and Xiaojun Wu _

Hengyu Li1,*, Zhuo Cheng2,*, Wei Huang3,*, Chenguang Bai1, Jian Lin4, Yuan Sheng1, Weifeng Shen5 and Xiaojun Wu6

1The Fourth Department of General Surgery, Changhai Hospital, Second Military Medical University, Shanghai 200433, China

2Eastern Hepatobiliary Surgery Institute, Second Military Medical University, Shanghai 200438, China

3Department of Minimally Invasive Neurosurgery, First Affiliated Hospital, Kunming Medical College, Kunming 650032, China

4Department of Pathology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China

5Department of Liver Transplantation, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China

6Department of Neurosurgery, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China

*These authors contributed equally to this work

Correspondence to:

Xiaojun Wu, email: [email protected]

Weifeng Shen, email: [email protected]

Yuan Sheng, email: [email protected]

Keywords: endothelial cells; Nogo-B; hepatocellular carcinoma; glioma; TGF-β

Received: April 07, 2017 Accepted: November 15, 2017 Published: January 03, 2018

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 23672

Publication Alerts

Post-Publication Promotion

Withdrawal Notice

Research Papers:

Endothelial Nogo-B suppresses cancer cell proliferation via a paracrine TGF-β/Smad signaling